- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The contraindicated population for Gefitinib includes individuals with a specific history of allergies, severe liver dysfunction, and pregnant ...
The standard usage of Gefitinib is once daily oral administration of 250mg, taken on an empty stomach or 2 hours after meals. Special populatio...
Metirapone is mainly used for the diagnosis and treatment of Cushing's syndrome, and its side effects involve multiple systems, but most can be...
Metirapone is mainly used for the diagnosis and treatment of Cushing's syndrome, exerting its effects by inhibiting the synthesis of adrenal co...
Futibatinib is a targeted anti-cancer drug, and its use must strictly follow contraindications, foods, and restrictions to ensure efficacy and ...
Futibatinib is a targeted FGFR kinase inhibitor used to treat specific cancer patients. The following will provide a detailed explanation of it...
Everolimus is an mTOR inhibitor with anti-tumor and immunomodulatory effects, mainly used to treat specific cancers and rejection reactions aft...
Everolimus, as an mTOR inhibitor, has shown significant efficacy in various indications, but standardized discontinuation is necessary to avoid...
Sorafenib, as a multi kinase inhibitor, has clear contraindications, dietary restrictions, and medication constraints when used. This article w...
Sorafenib, as a multi-target kinase inhibitor, has side effects that involve multiple systems and require targeted mitigation measures. This ar...
